A PYMNTS Company

EU Deciding On Medical Testing $17.4B Deal By December

By  |  November 3, 2021
Medical

EU antitrust regulators will decide by Dec. 7 whether to clear US medical device company Thermo Fisher Scientific’s $21 billion bid for contract research firm PPD, a European Commission filing showed on Wednesday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Thermo Fisher, the world’s largest maker of scientific instruments, announced the deal in April. The contract research industry is rebounding from pandemic disruption amid growing demand for virtual clinical trials.

    The European Commission can clear the deal with or without concessions at the end of its preliminary review or it can open a four-month long investigation if it has serious concerns.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.